Polycystic Ovary Syndrome

    January 2009 in “ PubMed
    David J Cahill
    TLDR PCOS affects many women and can cause various health issues, with several treatments available.
    Polycystic ovary syndrome (PCOS) was diagnosed in up to 10% of women attending gynecology clinics, with associations to hirsutism, infertility, acne, weight gain, type 2 diabetes, cardiovascular disease, and endometrial hyperplasia. A systematic review was conducted to evaluate the effects of various treatments, including finasteride, flutamide, metformin, spironolactone, cyproterone acetate-ethinylestradiol (co-cyprindiol), weight loss interventions, ketoconazole, and mechanical hair removal. The review included 24 systematic reviews, RCTs, or observational studies, and a GRADE evaluation was performed to assess the quality of evidence for these interventions.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Monthly Reminder.

       8 upvotes 6 years ago
      Various treatments for male pattern baldness including Minoxidil, Finasteride/Dutasteride, hair systems, and oral anti-androgens such as Spironolactone and Flutamide. It also mentions dermarolling as a possible treatment in conjunction with minoxidil.

      community Are these all the anti androgen products?

      in Treatment  6 upvotes 1 year ago
      The conversation lists hair loss treatments including finasteride, dutasteride, RU58841, pyrilutamide, breezula, and fluridil, and suggests ketoconazole as another option. Some users warn against using certain treatments like cyproterone acetate, bicalutamide, and spironolactone due to their strong anti-androgen effects and potential impact on masculinity.

      community Overwhelming amount of anti-androgens

      in Female 1 year ago
      The conversation discusses the effectiveness of anti-androgens for hair loss, with a preference for topical treatments like RU58841 over oral options due to better scalp concentration and fewer side effects. Topical finasteride at 0.1% may provide some results, especially when combined with a topical androgen receptor antagonist like RU58841.

    Related Research

    6 / 6 results